Shanghai Asia Business Investment Consulting Foreword: Don’t be afraid of the ups and downs of the market, decipher the funds on the Dragon and Tiger List, track the trends of front-line hot money and institutional funds, and identify short-term hot spots and strong stocks.
１. Market information
The three major indexes adjusted across the board yesterday, with the Shanghai Stock Exchange falling below the 3,000-point mark again, the ChiNext Index falling nearly 2% in late trading, the Beixin 50 Index rising by more than 7%, and nearly a hundred Beixin stocks rising by more than 10%. Funds continue to cling to high stocks, including Dongan Power with 9 consecutive boards, Huifa Food with 8 consecutive boards, Nanjing Business Travel with 6 consecutive boards, and Xinyada and Zhongguang Tianze with 4 consecutive boards.
Consumer stocks such as food, dairy, and prepared vegetables rose. Western Animal Husbandry rose by 20cm, and many stocks such as Sunshine Dairy, Yiming Food, Nanqiao Food, Anji Food, and Haixin Food were closed.
In terms of decline, computing power concept stocks fell, with Hengrun Co., Ltd. and Hengwei Technology falling by the limit; short drama concept stocks fell, with Yinsai Group falling by more than 10%.
In terms of sector concepts, sectors such as dairy, food, diet pills, and prepared dishes were among the top gainers, while sectors such as industrial chain, satellite navigation, ChatGPT, and games were among the top losers. The total turnover of the two cities was 822.5 billion yuan, a decrease of 28.7 billion yuan from the previous trading day, and the net sales of northbound funds were 7.5 billion yuan. Generally speaking, individual stocks fell more than they rose, with more than 4,600 stocks falling in the market.
In terms of individual stock sentiment, comparison of the rise and fall of stocks in the two cities418:4613, comparison of the rise and fall of stocks in the two cities 40:12, 17 stocks exploded, with a blast rate of 31 %.
On the market, yesterday's decline was extremely damaging. The market closed with a barren line, and as of the close, the risk release in the market was not complete. In the short term, there may still be some downside momentum. Please pay attention to the corresponding situation. Position control.
However, with the continued efforts on the policy front, the domestic stabilization of growth has been strengthened, which may promote the growth of A-share earnings. Combined with the current low valuation level of the market, there is no need to be too pessimistic about the market outlook. Wait for the index to show a clear signal of stopping falling and stabilizing, and then choose opportunities to buy low. From a medium to long-term perspective, the opportunities still outweigh the risks.
Data source: Financial Associated Press
Yesterday, the consumer sector bucked the trend and strengthened, among which the food and beverage sector was among the top gainers. Among them, Huifa Food had 8 consecutive stocks, Western Animal Husbandry had a daily limit of 20CM, and stocks such as Yiming Food, Anji Food, Nanqiao Food, and Haixin Food had a daily limit.
On the news, Bestore recently announced its largest price cut in 17 years, involving more than 300 of the company's products, with an average price cut of 22% and a maximum drop of 45%. Stimulated by this, Bestore rose by more than 20% in three trading days.
From a valuation perspective, after the early correction, food and beverages have entered a reasonable layout range, and the valuation of some companies has been lower than the average level in recent years. It is expected that industry valuations will be stable in 2024, and the sector still needs to return to the main line of performance growth.
Data source: Flush
Second. Investment Jujiao
1. Dragon and Tiger Decryption:
Analysis of the capital data of the Dragon and Tiger List on December 5. The top five net purchases of funds on the Dragon and Tiger List are: Tibet Mining, Tonghua Jinma, Changshan Pharmaceutical, Yunnei Power, Western Animal Husbandry, net purchases of funds were 250 million yuan, 117 million yuan, 113 million yuan, 85.28 million yuan, and 81.25 million yuan respectively. The top of the list of funds was Tibet Mining, a small metal stock. .
The above data comes from Flush. The individual stocks involved in the article are for display only and are not intended to be shared tips. They do not constitute investment advice. Please operate at your own risk.
2.The top three funds in the Dragon and Tiger List
①Tibet Mining（000762), yesterday took the top spot on the Dragon Tiger List. It belongs to the sector: small metals. The net amount of funds bought was 250 million yuan, and institutional buying was obvious. Reasons for inclusion on the list: Securities with a cumulative increase deviation of 20% within three consecutive trading days.
1. According to a reporter from China Securities Journal, a state-owned capital operating company entered the market yesterday to buy ETF products of multiple public fund companies. It is reported that most of the ETF products purchased are products tracking the central enterprise index.
2. The company is a state-owned enterprise. The company’s controlling shareholder is Tibet Mining Assets Management Co., Ltd., and its ultimate controller is the State-owned Assets Supervision and Administration Commission of the State Council.
3. The company is the largest comprehensive mineral product development company in Tibet, mainly engaged in the mining, processing, sales and trading of chromite and lithium ore.
The main products are chromite, lithium ore, lithium and its compounds. The Zabuye Salt Lake in Tibet, where the company has the exclusive mining rights, is the third largest lithium salt lake in the world and the largest in Asia. The proven lithium reserves are 1.841 million tons. It is a special salt lake rich in solid and liquid lithium, boron and potassium. Comprehensive large salt lake deposit.
Data source: Flush
②Tonghua Golden Horse（000766), the net amount of funds purchased was 117 million yuan, and the sector it belongs to: chemical pharmaceuticals. Reason for being on the list: Securities with a daily increase deviation of 7%.
1. Interaction on November 28: The company has a variety of cold medicine products. Interaction on November 29: The company’s products include a variety of children’s medicines.
2. The company announced on September 20: Recently, the company’s wholly-owned subsidiary Changchun Huayang has made significant research progress in the amber octahydroaminoacridine tablets project independently developed.
3. The company and its wholly-owned subsidiary Changchun Huayang High-Tech Co., Ltd. independently developed and has an exclusive patented chemical drug Class I.I new drug Amber Octahydroaminoacridine Tablets for the treatment of mild and moderate Alzheimer's disease. The plan is progressing in an orderly manner, and the blind data review has been successfully completed.
4. The company is mainly engaged in the research and development, production and sales of pharmaceutical products. The main products are compound Lactobacillus acidophilus tablets, Fengshi Qutong capsules, Qinggan Jianpi oral liquid, and Qinshi Liyan oral liquid.
Data source: Flush
③Changshan Pharmaceutical(300255), net The total purchase amount is 113 million yuan, and the sector it belongs to: chemical pharmaceuticals. Reasons for being on the list: Securities with a daily closing price increase of 15% that have a price limit.
1. On the news, Roche announced that it has agreed to acquire Carmot Therapeutics, an unlisted US weight loss drug developer, for an upfront price of US$2.7 billion. Roche said that according to the transaction contract, the transaction is expected to be completed in the first quarter of 2024. The company's shareholders could receive $400 million if the developer's drug achieves individual milestones. For Roche, the deal marks the company's return to the GLP-1 arena.
2. The company's ebenatide and semaglutide are both GLP-1 drugs, and the company is actively promoting the new drug approval of ebenatide.
3. The company’s main business is the research, development, production and sales of drugs for the treatment of cardiovascular and cerebrovascular diseases. The company is one of the few leading companies in China that has a complete heparin product industry chain and is able to engage in the research, development, production and sales of crude heparin, heparin raw materials and heparin preparations.
Data source: Flush
3. Institutional funds participate in the top five stocks:
Yesterday, the stock with the highest institutional capital participation among the top five was Yidao Information, which belongs to the consumer electronics industry.
1. The record of recent investor relations activities shows that the company has actively followed up on mainstream models such as Big Language and AIGC. It is developing a PC platform specially designed for generative AI, which can generate images through StableDiffusion on the PC side. The company's mission is to "make cutting-edge technology more approachable".
2. Interaction on November 1: At this stage, the company is paying more attention to the product practice of AI computing power on local terminals, such as smart speakers, smart conference systems, smart home central control products, XR products, etc.
Interaction on October 24: The company’s latest EM-R51 Hongmeng version ruggedized handheld terminal is based on OpenHarmony’s complete system capabilities and can better assist the digital development of the smart terminal industry; the company’s cost-effective lightweight MR products are being developed and promoted It is advancing in an orderly manner and has officially appeared at the 2023 World VR Industry Conference in Nanchang.
3. The company’s listing date is 2023-02-14, and its main business is the research and development, design, production and sales of electronic equipment such as laptops, tablets and other smart hardware.
4. Yijing Virtual is committed to bringing cutting-edge technologies such as three-dimensional display and spatial computing technology and wearable computing technology into the homes of ordinary people, and strives to realize the freedom of the metaverse as soon as possible.
Data source: Flush
4. The top five stocks with hot capital participation in the Dragon and Tiger List:
Yesterday, the top five stocks on the Dragon and Tiger list all hit their daily limit.
Tonghua Jinma (Chemical Pharmaceuticals) has attracted the attention of quantitative funds and front-line hot money;
Yunnei Power (auto parts) has gained the attention of quantitative boarding and Foshan-based hot money;
Yidao Information (consumer electronics) has attracted the attention of quantitative market makers and quantitative fund hot money;
Xinyada (computer application) has attracted the attention of Zhang League Leader Hot Money;
Weishi Electronics (optical optoelectronics) has attracted the attention of hot money from Ningbo Sangtian Road and Huzhou Labor Road.
Data source: Flush
3. both altitude
Continuously listed stocks:The total number of consecutively listed stocks yesterday was15,the two cities had the highest consecutive board with nine consecutive boards of Dongan Power (auto parts).
Changan Automobile's concept shareholder Anli has 9 connected boards, prepared dish concept Huifa Food has 8 connected boards, retail and cross-border e-commerce Nanjing Business Travel has 6 connected boards, and financial technology concept Xinyada has 4 connected boards.
With the stock index showing a unilateral trend of bottoming out, the purely emotional crowding of funds has once again strengthened, and the height of the board has further increased. At the same time, Shenglong shares and other early-stage old dragons have successively started to restore the market, and the market metaphysical speculation has revived.
However, Dongan Power, which is on the 9th board, and Huifa Food, which is on the 8th board, have also triggered changes one after another. Therefore, some even-listed stocks also experienced fund rush movements during the session, and the ultra-short-term speculative direction sentiment may face certain differences.
Reference materials: Tonghuashun, Cailianshe
Statement: The above content comes from the Financial Research Institute of Shanghai Yashang Investment Consulting Co., Ltd. This page is based on public data. It compiles and compiles the public information. It represents the views and judgments on the date of release. The completeness and accuracy of the information are not guaranteed. It is for learning reference only and does not constitute investment advice. Investors should choose carefully, make decisions independently, and bear their own risks. Investments are risky and they need to be cautious when entering the market.